Pepticom is launching a Webinar series
The webinar series is about the world of Peptide Therapeutics, in the first couple of episodes we are hosting Dr. Tomi Sawyer, our head of the scientific advisory board. We’ll share breakthroughs in the field, what the future is and where Pepticom fits in.To watch all episodes, follow us here: https://pepticom.com/to-our-webinar/
Dr. Tomi Sawyer nominated as Head of SAB
The Pepticom team are thrilled to announce that Dr. Tomi Sawyer, a world leading Key Opinion Leader (KOL) in the field of peptide drug discovery, and a current member of the Pepticom scientific advisory board, has been nominated as the Head of the Pepticom Scientific Advisory Board! Among his many accolades, Tomi is renowned for […]
Dr. Richard Soll is joining Pepticom’s SAB
We are very excited to announce Dr. Soll joining Pepticom’s Scientific Advisory Board.Presently Senior Advisor, Strategic Initiatives at WuXi AppTec and Head of the WuXi office in Boston, Massachusetts, Dr. Soll’s contributions have led to the discovery of the HCV NS5A inhibitor in the Merck-WuXi partnership, the JAK2 inhibitor Fedratinib at TargeGen (partnered with Celgene/BMS), […]
Sarah Benson-Konforty joining the Advisory Board
We’re thrilled to announce that Sarah Benson-Konforty, MD has joined Pepticom’s Advisory Board. Sarah is a serial entrepreneur, executive, board member, tech Investor and a medical doctor based in Silicon Valley. She brings a vast experience in business strategy and operations, investments and growth across multiple industries including health.
Pepticom at the MIXiii Health-Tech.IL
MIXiii Health-Tech.IL is the annual get together for the Life Science & Health Tech Industries in Israel, on November 9-10, 2022 at the ICC Jerusalem.We’re hosting a booth so come by and hear about all we’re doing in novel peptide therapeutics and intelligent peptide design. On the first day we’ll be at the bio Jerusalem Startup […]